Abstract: The invention relates to a liposomal composition, containing a citrus type (Aurantioideae) essential oil of pharmaceutical grade 0.5-5.0 part by weight; lavender oil of pharmaceutical grade 0.5-5.0 part by weight; vitamin E 0.1-1.5 part by weight; vitamin A 0.1-1.5 part by weight; castor oil ethoxylated 1.0-6.0 part by weight; a phospholipid 0.1-1.0 part by weight; distilled water 15-30 part by weight; ethanol 96% 65-75 part by weight. The composition can be used for treatment of wounded, burned, frozen, infected skin surfaces.

Abstract: The present invention relates to a setup (100) for constructing a weed map. The setup (100) comprises an image recording unit (110; 110?) having a video camera (112) and a relief-tracking laser camera (114), an image processing and evaluating unit (120), a data storage unit (130) connected to the latter, as well as a weed database (135). The setup (100) also comprises a light source (160), a position detection unit (150) equipped with a location finding element (152) and a location refining element (154) for determining the spatial coordinates supplied by the former more accurately. The image recording unit (110; 110?), the position detection unit (150) and the light source (160) are all in data communication connection with the image processing and evaluating unit (120).

Abstract: The invention relates to a chuck for flexible manufacturing, said chuck comprising a chuck body, a central draw head guided axially in a central hole of the chuck body and connected to inner jaws radially guided in the chuck body through a straight-wedge mechanism, and outer jaws also radially guided in the chuck body and adapted to be equipped with chuck jaws for chucking a work-piece and to be engaged with coupling heads through rack teeth. The coupling heads are built in the inner jaws and guided axially therein, wherein said coupling heads comprise a double locking coupling device. The first locking stage of said coupling device includes wedge-shaped control members fixed to a control ring, whereas the second locking stage includes an additional locking member directly connected to the control ring. The chuck body is in the form of a one-piece unit, wherein the control ring is encased by the chuck body and the rear centering disc so that the control ring can be rotated there-between.

Abstract: The invention relates to a liposomal composition, containing a citrus type (Aurantioideae) essential oil of pharmaceutical grade 0.5-5.0 part by weight; lavender oil of pharmaceutical grade 0.5-5.0 part by weight; vitamin E 0.1-1.5 part by weight; vitamin A 0.1-1.5 part by weight; castor oil ethoxylated 1.0-6.0 part by weight; a phospholipid 0.1-1.0 part by weight; distilled water 15-30 part by weight; ethanol 96% 65-75 part by weight. The composition can be used for treatment of wounded, burned, frozen, infected skin surfaces.

Abstract: The present invention relates to a setup (100) for constructing a weed map. The setup (100) comprises an image recording unit (110; 110?) having a video camera (112) and a relief-tracking laser camera (114), an image processing and evaluating unit (120), a data storage unit (130) connected to the latter, as well as a weed database (135). The setup (100) also comprises a light source (160), a position detection unit (150) equipped with a location finding element (152) and a location refining element (154) for determining the spatial coordinates supplied by the former more accurately. The image recording unit (110; 110?), the position detection unit (150) and the light source (160) are all in data communication connection with the image processing and evaluating unit (120).

Abstract: The invention relates to a chuck for flexible manufacturing, said chuck comprising a chuck body (1), a central drawhead (5) guided axially in a central hole of the chuck body (1) and connected to inner jaws (4) radially guided in the chuck body (1) through a straight-wedge mechanism, and outer jaws (7) also radially guided in the chuck body (1) and adapted to be equipped with chuck jaws for chucking a work-piece and to be engaged with coupling heads (5) through rack toothings (6). The coupling heads (5) are built in the inner jaws (4) and guided axially therein, wherein said coupling heads (5) comprise a double locking coupling device. The first locking stage of said coupling device includes wedge-shaped control members (10) fixed to a control ring (9), whereas the second locking stage includes an additional locking member directly connected to the control ring (9).

Abstract: The invention relates to a chuck with chuck jaws (2) which are guided in the chuck housing (1). Inner jaws (4) which can be coupled or uncoupled are assigned directly or indirectly to said chuck jaws via rack gears (3), whereby the inner jaws (4) are connected to a central pulling head (12) via a wedging mechanism. The pulling head is connected via a rod or hollow shaft (13), said rod or hollow shaft being guided in a central bore of the main spindle (25), to the piston of a hydraulic cylinder arranged on the rear part of the main spindle (25).

Abstract: This invention provides liposomic composition, containing as active ingredient (-)-N-.alpha.-dimethyl-N-(2-propynylphenylethylamine) (selegilin) and/or salt thereof. This composition contains: 0.1-40% by weight of selegilin and/or a salt thereof, 2 to 40% by weight of lipids, preferably phospholipids, 0 to 10% by weight of cholesterol, 0 to 20% by weight of an alcohol, 0 to 25% by weight of a glycol, 0 to 3% by weight of an antioxidant, 0 to 3% by weight of a preserving agent, 0 to 2% by weight of a viscosity influencing agent, 0 to 50% by weight of cyclodextrin or a cyclodextrin derivative and 30 to 90% by weight of water. This invention relates to pharmaceutical composition, containing the liposomic composition described and if desired, usual filling and diluting agents and other auxiliaries, preferably in oral, parenteral or transdermal form. This invention provides the process for the preparation of liposomic compositions containing selegilin and/or salt thereof.

Abstract: The invention relates to two phase pharmaceutical compositions comprising as active ingredient a MAO inhibitor and an uptake inhibitor together with usual pharmaceutical auxiliaries. The compositions can be used for the treatment of neurodegenerative diseases. As active ingredient optionally N-(1-phenyl-isopropyl)-N-methyl-propinylamine or N-(4-fluoro-phenyl)-isoprop-1-yl-N-methyl-propinylamine or their salts, optically active isomers or metabolites are used both as MAO inhibitor and as uptake inhibitor.

Abstract: The invention relates to inclusion complexes of N-ethoxycarbonyl-3-morpholino-sydnonimine or its salts formed with a cyclodextrin derivatives, preparation thereof and pharmaceutical compositions containing the same.The inclusion complex of N-ethoxycarbonyl-3-morpholino-sydnonimine or its salt formed with cyclodextrin derivative is prepared bya) reacting the N-ethoxycarbonyl-3-morpholino-sydnonimine or its salt and the cyclodextrin derivative in a solvent medium, and if desired recovering the complex from the solution by dehydration, orb) high energy milling of the N-ethoxycarbonyl-3-morpholino-sydnonimine or its salt and the cyclodextrin derivative.

Abstract: The invention relates to inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof and pharmaceutical compositions containing the same.The inclusion complex of 3-morpholino-sydnonimine or its salt formed with cyclodextrin derivative is prepared bya) reacting the 3-morpholino-sydnonimine or its salt in an aqueous medium with a cyclodextrin derivative and the complex is isolated from the solution by dehydratation, orb) high energy milling of 3-morpholino-sydnonimine or its salt and a cyclodextrin derivative.

Abstract: The invention relates to novel compounds of the general formula (I), ##STR1## The compounds of the invention antagonize the effects of constrictive mediators, e.g. histamine, acetylcholine or serotonin; they show an antiallergic action and possess an antiinflammatory effect. Thus, these compounds can therapeutically be used as bronchodilators as well as antiallergic or antiinflammatory drugs, particularly in the treatment of bronchial asthma.

Abstract: The invention relates to novel compounds of the general formula (I), ##STR1## wherein R means hydrogen or a straight or branched chain C.sub.1-6 alkoxy group;R.sup.1 stands for hydrogen or a straight or branched chain C.sub.1-6 alkyl group;R.sup.2 represents hydrogen or a straight or branched chain C.sub.1-6 alkyl group;R.sup.3 means hydrogen, a straight or branched chain C.sub.1-6 alkyl group optionally substituted by one or two hydroxyl and/or one or two straight or branched chain C.sub.1-4 alkoxy group(s); or a C.sub.4-7 cycloalkyl group;R.sup.4 stands for hydrogen or a straight or branched chain C.sub.1-6 alkyl group optionally substituted by one or two hydroxyl and/or one or two straight or branched chain C.sub.1-4 alkoxy group(s); or a C.sub.4-7 cycloalkyl group; orR.sup.3 and R.sup.4 together with the nitrogen atom, to which they are attached form a 4 to 8-membered cyclic group of formula ##STR2## optionally substituted by one or two straight or branched chain C.sub.

Abstract: The invention relates to novel racemic or optically active berban derivatives of the formula (I) ##STR1## wherein R.sup.1 and R.sup.2 represent independently from the other a hydroxyl, straight or branched chain alkoxy group 1 to 6 carbon atoms or R.sup.1 and R.sup.2 together represent a C.sub.1-3 alkylenedioxy group;R.sup.3 and R.sup.4 represent independently from the other hydrogen, straight or branched chain alkyl group, having 1 to 6 carbon atoms and optionally substituted by hydroxyl group, or a C.sub.2-6 alkoxycarbonyl or cyano group; andR.sup.5 represents hydrogen, straight or branched chain alkyl group having 1 to 6 carbon atoms, C.sub.1-7 aliphatic or aromatic acyl group or C.sub.1-7 alkylsulphonyl or arylsulphonyl group, anda salt thereof, to pharmaceutical compositions containing them, to the use as well as to process for preparing the novel compounds. The compounds of the formula (I) are selective .alpha..sub.